-
Hepatocellular Carcinoma After Hepatitis C Cure: Study Emphasizes The Need for Long-Term Surveillance
07 Feb 2025 17:20 GMT
… did not contribute to HCC development, and recurrences were primarily reported … exact mechanisms driving HCC development post-DAA treatment remain uncertain, the … carcinoma after treatment of hepatitis C with direct-acting antiviral drugs. Annals of …
-
Non-Hodgkin's Lymphoma Clinical Trial Pipeline | 200+ Companies Driving Innovation to Transform Treatment
07 Feb 2025 16:47 GMT
… develop 220+ pipeline drugs for Non-Hodgkin's Lymphoma treatment. … -Hodgkin's Lymphoma medication @ https:/… III clinical trials for the treatment of Non- … store/hepatitis-c-virus-infection-pipeline-insight
Hepatitis C Market: https …
-
Philly's cure rate for hepatitis C has risen to nearly 60% over the last decade
05 Feb 2025 23:30 GMT
… been such incredible treatment for hepatitis C that has happened … develop hepatitis B "can live a long life with effective treatment … .
Antiviral medications can treat and often cure hepatitis C.
Acute … among people who use drugs, according to the report …
-
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
07 Feb 2025 09:01 GMT
… B, hepatitis C, and metabolic dysfunction-associated steatohepatitis.3,4
Treatment recommendations for … in patients with hepatoCEllular carcinoma) trial was conducted from 2013 to … factors, diagnosis and treatment. Open Access Maced J Med Sci. 2015;3 …
-
Promacta interactions: Alcohol, medications, and other factors
05 Feb 2025 17:57 GMT
… treatment options that don’t affect Promacta or other medications … For example, in clinical trials of Promacta, doctors often … an increased risk of developing acute myeloid leukemia. If … Southeast Asian ancestry and have hepatitis C, your doctor will likely …
-
Sales Include Former Mayville Restaurants, Jamestown Health Clinic
08 Feb 2025 08:47 GMT
… health testing and treatments, HIV prevention and care, Hepatitis C care, transgender care … market the property for manufacturing development.
From Nov. 25-27, there … ...
MAYVILLE – Opening arguments of a trial for a New Jersey man …
-
Phase 3 waveLINE-010 Study Starts for Zilovertamab Vedotin in DLBCL
07 Feb 2025 23:54 GMT
… with a history of hepatitis C virus (HCV) infection may … dose confirmation and expansion trial (NCT05139017) for treating … phase 3 waveLINE-010 trial initiation evaluating zilovertamab vedotin, … drug conjugate, for the treatment of patients with previously …
-
CHMP Pushes 3 Biosimilars Forward, Spelling Hope for Ophthalmology, Supportive Care Markets
07 Feb 2025 03:31 GMT
… immune thrombocytopenia and chronic hepatitis C virus.
New Indications … , melanoma as adjuvant treatment, resectable or metastatic … are in development, including candidates being developed by Innovent … and providing greater medication access to patients …
-
3 Top AI-Powered Biotech Stocks to Buy in February
07 Feb 2025 02:11 GMT
… strong sales of blockbuster autoimmune drugs Skyrizi and Rinvoq -- … global markets for HIV and hepatitis C treatments while making impressive progress diversifying … option to commercialize potential products developed through the program. These initiatives …
-
Vosevi side effects and how to manage them
06 Feb 2025 20:05 GMT
… for chronic (long-lasting) hepatitis C.
If you have problems with … effects of the medication. If you develop a side effect … effects occurred in clinical trials, see the prescribing information … a headache during Vosevi treatment, over-the-counter pain …